LABORATORY RESEARCH USE ONLY β This compound is NOT for human consumption, veterinary use, or therapeutic applications.
GLP-1/Glucagon Dual AgonistsMetabolic Research㪠RUO
Survodutide
Molecular Data
Formula
C195H298N48O60
Mol. Weight
4300.00 Da
CAS Number
2375218-63-0
Purity
β₯95% (HPLC)
Appearance
White lyophilized powder
Storage
-20Β°C, desiccated
Research Overview
Survodutide is a dual GLP-1 and glucagon receptor agonist under investigation for metabolic and hepatic research applications.
Mechanism of Action
Dual activation of GLP-1 and glucagon receptors, combining appetite suppression with enhanced hepatic lipid oxidation and energy expenditure.
Research Applications
Dual agonist pharmacology, MASH/NASH modeling, hepatic lipid metabolism, energy expenditure research, liver fibrosis investigation.
Key Research Findings
Significant hepatic fat reduction in preclinical models. Dual mechanism addresses both metabolic and hepatic pathology.
MANDATORY DISCLAIMER: Survodutide as referenced on this page is strictly for in-vitro laboratory research and forensic applications only. It is NOT for human consumption, veterinary use, diagnostic purposes, therapeutic applications, or any form of bodily introduction. Any reference to research outcomes pertains exclusively to controlled laboratory settings. Researchers must comply with all applicable local, state, and federal regulations.
